Uptake and retention of the photosensitizer mono-L-asparthyl chlorine e6 in experimental malignant glioma

Lasers in Medical Science

Volumn 23, Issue 3, 2008, Pages 237-245

  Matsumura, Hiroyuki ^a   Akimoto, Jiro ^a   Haraoka, Jo ^a   Aizawa, Katsuo ^a  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

Malignant glioma; Mono L aspartyl chlorine e6 (NPe6); Photodynamic diagnosis; Photosensitizer

Indexed keywords

AMINOLEVULINIC ACID; CHLOROPHYLL; TALAPORFIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER GRAFT; CELL DENSITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIODE LASER; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG DOSE ESCALATION; FLUORESCENCE; GLIOBLASTOMA; GLIOMA CELL; HISTOPATHOLOGY; IRRADIATION; MALE; NONHUMAN; PHOTODYNAMICS; PRIORITY JOURNAL; RAT;

ANIMALS; BRAIN NEOPLASMS; CELL LINE, TUMOR; GLIOMA; LASERS; MALE; NEOPLASM TRANSPLANTATION; PHOTOSENSITIZING AGENTS; PORPHYRINS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 45749151513     PISSN: 02688921     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10103-007-0469-3     Document Type: Article

References (35)

1. Lacroix M, Abi-Said D, Fourney DR, Gokaslan ZL, Shi W, DeMonte F, Lang FF, McCutcheon IE, Hassenbusch SJ, Holland E, Hess K, Michael C, Miller D, Sawaya R (2001) A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. J Neurosurg 95:190-198
2. Sawaya R, Hammound M, Schoppa D, Hess KR, Wu SZ, Shi WM, Wildrick DM (1998) Neurosurgical outcomes in a modern series of 400 craniotomies for treatment of parenchymal tumors. Neurosurgery 42:1044-1056
3. Moore GE, Peyton WT, French LA (1948) The clinical use of fluorescein on neurosurgery. The localization of brain tumors. J Neurosurg 5:392-398
4. Stummer W, Novotny A, Stepp H, Goetz C, Bise K, Reulen HJ (2000) Fluorescence-guided resection of glioblastoma multiforme by using 5-aminolevulinic acid-induced porphyrins: a prospective study in 52 consecutive patients. J Neurosurg 93:1003-1013
5. Stummer W, Pichlmeier U, Meinel T, Wiestler OD, Zanella F, ReulenHJ (2006) Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomized controlled multicentre phase III trial. Lancet Oncol 7:392-401
6. Bellnier DA, Ho YK, Pandey RK, Missert JR, Dougherty TJ (1989) Distribution and elimination of Photofrin II in mice. Photochem Photobiol 50(2):221-228
7. Kaye AH, Morstyn G, Ashcroft RG (1985) Uptake and retention of hematoporphyrin derivative in an in vivo/in vitro model of cerebral glioma. Neurosurgery 17:883-890
8. Kaye AH, Morstyn G, Apuzzo ML (1988) Photoradiation therapy and its potential in the management of neurological tumors. J Neurosurg 69:1-14
9. Muller PJ, Wilson BC (1996) Photodynamic therapy for malignant newly diagnosed supratentorial gliomas. J Clin Laser Med Surg 4:263-270
10. Perria C, Capuzzo T, Cavagnaro C, Datti R, Francaviglia N, Rivano C, Tercero VE (1980) First attempts at the photodynamic treatment of human gliomas. J Neurosurg Sci 24:119-129
11. Perria C, Carai M, Falzoi A, Orunesu G, Rocca A, Massareli G, Francaviglia N, Joli G (1998) Photodynamic therapy of malignant brain tumors: clinical results of, difficulties with, questions about, and future prospects for the neurosurgical applications. Neurosurgery 23:557-563
12. Popovic EA, Kaye AH, Hill JS (1995) Photodynamic therapy of brain tumors. Sem Surg Oncol 11:335-345
13. Hill JS, Kaye AH, Sawyer WH, Morstyn G, Megison PD, Stylli SS, Koo MS, Gonzales MF, Vardaxis NJ, Johnson CI (1990) Selective uptake of hematoporphyrin derivative into human cerebral glioma. Neurosurgery 26:248-254
14. Hill JS, Kahl SB, Kaye AH, Stylli SS, Koo MS, Gonzales MF, Vardaxis NJ, Johnson CI (1992) Selective tumor uptake of a boronated porphyrin in an animal model of cerebral glioma. Proc Natl Acad Sci U S A 89:1785-1789
15. Aizawa K, Okunaka C, Ohtani T, Kawabe H, Yasunaka Y, O'Hata S, Ohtomo N, Nishiyama K, Konaka C, Kato H, Hayata Y, Saito T (1987) Localization of mono-l-aspartyl chlorine e6 (NPe6) in mouse tissue. Photochem Photobiol 46(5):789-793
16. Kessel D (1997) Pharmacokinetics of N-aspartyl chlorine e6 in cancer patients. J Photochem Photobiol B 39:81-83
17. Roberts WG, Berns MW (1989) In vitro Photosensitization I. Cellular uptake and subcellular localization of Mono-l-asparthyl Chlorin e6, Chloro-aluminuim sulfonated phthalocyanine, and Photofrin II. Lasers Surg Med 9:90-101
18. Kessel D, Whitcomb KL, Schulz V (1992) Lipoprotein-mediated distribution of N-aspartyl chlorine-E6 in the mouse. Photochem Photobiol 56:51-56
19. Kessel D (1995) Interactions between N-aspartyl chlorine e6, detergent micelles and plasma lipoproteins. Photochem Photobiol 61:646-649
20. Tsuchida T, Aizawa K, Konaka C, Kato H (1993) Interaction of bovin serum albumin with mono-l-aspartyl chlorine e6 by spectrophotometry. Lasers Life Sci 5:155-164
21. Sheyhedin I, Okunaka T, Kato H, Yamamoto Y, Sakaniwa N, Konaka C, Aizawa K (2000) Localization of experimental submucosal esophageal tumor in rabbits by using mono-l-aspartyl chlorine e6 and long-wavelength photodynamic excitation. Lasers Surg Med 26:83-89
22. Dougherty TJ, Kaufman JE, Goldfarb A, Weishaupt KR, Boyle DG, Miffelman A (1978) Photoradiation therapy. a new method for the treatment of malignant tumors. Cancer Res 38:2628-2635
23. Dougherty TJ (1987) Photosensitizers. Therapy and detection of malignant tumors. Photochem Photobiol 45:879-889
24. Kennedy JC, Pottier RH (1991) Endogeneous protoporphyrin IX, a clinically useful Photosinsitizer for photodynamic therapy. J Photochem Photobiol B 30:14(4)275-292
25. Ferrario A, Kessel D, Gomer CJ (1992) Metabolic properties and photosensitizing responsiveness of mono-l-aspartyl chlorine e6 in a mouse tumor model. Cancer Res 52:2890-2893
26. Gomer CJ, Ferrario A (1990) Tissue distribution and photosensitizing properties of mono-l-aspartyl chlorine e6 in a mouse tumor model. Cancer Res 50:3985-3990
27. Louis-Michel WKS, Wang KK, Zinsmeister AR (1998) Mono-l-aspartyl chlorine e6 (NPe6) and hematoporphyrin derivative (HpD) in photodynamic therapy administered to a human cholangiocarcinoma model. Cancer 82:421-427
28. Nakamura J, Sugiyama Y, Kajiwara H, Nakamura M, Watanabe M, Tanaka H, Terada T, Nagao J, Kusachi S, Saida Y, Usui S, Aizawa K (2000) [Photodynamic diagnosis and photodynamic therapy for experimental hepatoma with ME 2906]. Gan To Kagaku Ryoho 27:1876-1878
29. Knobler F, Poh-Fitzpatrick MB, Kravetz D, Vincent WR, Muller-Eberhand U, Vincent SH (1989) Interaction of hemopexin, albumin and liver fatty acid binding protein with protoporphyrin. Hepatology 10(6):995-997
30. Yuan F, Salehi HA, Boucher Y, Vasthare US, Tuma RF, Jain RK (1994) Vascular permeability and microcirculation of gliomas and mammary carcinomas transplanted in rat and mouse cranial windows. Cancer Res 54:4564-4568
31. Roberts WG, Liaw LHL, Berns MW (1989) In vitro photosensitization II. An electron microscopy study of cellular destruction with mono-l-aspartyl chlorine e6 and photofrin II. Lasers Surg Med 9:102-108
32. Roberts WG, Shiau FY, Nelson JS, Smith KM, Berns MW (1988) In vitro characterization of monoaspartyl chlorine e6 for photodynamic therapy. J Natl Cancer Inst 80:330-336
33. Nelson JS, Liaw LH, Orenstein A, Roberts WG, Berns ME (1988) Mechanism of tumor destruction following photodynamic therapy with hematoporphyrin derivative, chlorine, and phthalocyanine. J Natl Cancer Inst 80:1599-1605
34. Nelson JS, Roberts WG, Berns MW (1987) In vivo studies on the utilization of mono-l-aspartyl chlorine (NPe6) for photodynamic therapy. Cancer Res 47:4681-4685
35. Katsumi T, Aizawa K, Kuroiwa Y, Saito K, Kurata Y, Ii Y, Okunaka T, Konaka C, Kato H (1996) Photodynamic therapy with a diode laser for implanted fibrosarcoma in mice employing mono-l-aspartyl chlorine e6. Photochem Photobiol 64:671-675